Pluristem Therapeutics Inc. (PSTI:NASDAQ) soared at $1.83, representing a gain of 24.5%. The stock appeared on our News Catalysts scanner on Mon, Jan 10, 2022 at 03:10 AM in the 'PATNERSHIP' category. From Mon, Dec 27, 2021, the stock recorded 33.33% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Pluristem Therapeutics Inc. (PSTI:NASDAQ)
Pluristem Therapeutics Inc is a bio-therapeutics company. It is engaged in developing off-the-shelf allogeneic cell therapy products for treatment of ischemic & inflammatory, cardiovascular, orthopedic, pulmonary, hematological, & women's health diseases.
Top 10 Gainers:
- Zynga Inc. (ZNGA:NASDAQ), 40.67%
- MOLN (MOLN:NASDAQ), 30.46%
- RXST (RXST:NASDAQ), 28.21%
- BioCryst Pharmaceuticals, Inc. (BCRX:NASDAQ), 27.85%
- iRhythm Technologies, Inc. (IRTC:NASDAQ), 27.55%
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 26.96%
- APR (APR:NASDAQ), 26.11%
- Pluristem Therapeutics Inc. (PSTI:NASDAQ), 24.49%
- OLK (OLK:NASDAQ), 23.8%
- BFRI (BFRI:NASDAQ), 22.03%